Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 1	2026-10-09		NCT06376162

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kura Oncology	1
PedAL BCU, LLC	3

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Children's Healthcare of Atlanta	Atlanta	United States	38
Children's Hospital Colorado	Aurora	United States	312
Children's Hospital Los Angeles	Los Angeles	United States	226
Children's Hospital of Philadelphia	Philadelphia	United States	434
CHU de Nantes - Hôpital Femme-Enfant-Adolescent	Nantes	France	2
CHU de Reims - Hôpital Robert Debré	Paris	France	1
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	5
Dana-Farber Cancer Institute	Boston	United States	626
Fondazione IRCCS San Gerardo dei Tintori (Ospedale San Gerardo)	Monza	Italy	2
Hospital Infantil Universitario Niño Jesús	Madrid	Spain	21
Hospital Universitari Vall d'Hebrón	Barcelona	Spain	19
Memorial Sloan Kettering Cancer Center - New York	New York	United States	6
Ospedale Pediatrico Bambino Gesù	Roma	Italy	4
Prinses Maxima Centrum Kinderoncologie	Utrecht	Netherlands	3
Sankt Anna-Kinderspital	Vienna	Austria	1
Seattle Children's Hospital	Seattle	United States	281
SickKids - The Hospital for Sick Children	Toronto	Canada	3
St. Jude Children's Research Hospital	Memphis	United States	4
Texas Children's Hospital	Houston	United States	187

Clinical trials